Search results
Results from the WOW.Com Content Network
Cost-shifting implies price discrimination and price discrimination will be applicable if the pricing system allows it. Of the three conventional pricing models in the health care industry, including individual negotiation, collective negotiation, and unilateral pricing, only price discrimination can be implemented in the individual negotiation ...
[7] [8] [2] Price discrimination is distinguished from product differentiation by the difference in production cost for the differently priced products involved in the latter strategy. [2] Price discrimination essentially relies on the variation in customers' willingness to pay [8] [2] [4] and in the elasticity of their demand.
This amounted to 15% percent of U.S. GDP in that year, while Canada spent 10%. A study by Harvard Medical School and the Canadian Institute for Health Information determined that some 31% of U.S. health care dollars (more than $1,000 per person per year) went to health care administrative costs. [109]
Medical inflation is accelerating as demand for non-COVID-19-related health services recovers and providers seek to make up for soaring labor costs.
Discrimination based on price includes, but is not limited to: increased costs for basic services (health care, repair, etc.) increased costs for per diem charges (such as charging one person $40 while charging another person $100 for exactly the same service provided) [20] not offering deals, sales, rebates, etc. to minorities
Value-based health care (VBHC) is a framework for restructuring health care systems with the overarching goal of value for patients, with value defined as health outcomes per unit of costs. [1] The concept was introduced in 2006 by Michael Porter and Elizabeth Olmsted Teisberg , though implementation efforts on aspects of value-based care began ...
In a system of free-market healthcare, prices for healthcare products and services are set freely by agreement between patients and health care providers, which are subject to the laws and forces of supply and demand and free from any intervention by a government, price-setting monopoly, or other outside authority.
The Robinson–Patman Act (RPA) of 1936 (or Anti-Price Discrimination Act, Pub. L. No. 74-692, 49 Stat. 1526 (codified at 15 U.S.C. § 13)) is a United States federal law that prohibits anticompetitive practices by producers, specifically price discrimination.